370879-53-1 Usage
General Description
CIS-5-BENZYLTETRAHYDROPYRROLO[3,4-C]PYRROLE-1,3(2H,3AH)-DIONE is a chemical compound that belongs to the class of tetrahydropyrrolo pyrrole dione derivatives. It is a heterocyclic compound that contains a tetrahydropyrrole ring fused to a pyrrole ring with a benzylation at the 5-position of the tetrahydropyrrole ring. CIS-5-BENZYLTETRAHYDROPYRROLO[3,4-C]PYRROLE-1,3(2H,3AH)-DIONE has potential biological and pharmacological activities, and it is being studied for its therapeutic potential in various medical applications. Its precise uses and effects may vary depending on the specific context of its application, but it is generally recognized as an important chemical compound with significant potential for further research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 370879-53-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,7,0,8,7 and 9 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 370879-53:
(8*3)+(7*7)+(6*0)+(5*8)+(4*7)+(3*9)+(2*5)+(1*3)=181
181 % 10 = 1
So 370879-53-1 is a valid CAS Registry Number.
InChI:InChI=1/C13H14N2O2/c16-12-10-7-15(8-11(10)13(17)14-12)6-9-4-2-1-3-5-9/h1-5,10-11H,6-8H2,(H,14,16,17)/t10-,11+
370879-53-1Relevant articles and documents
QUINOLONE DERIVATIVES AS FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITORS
-
Page/Page column 85, (2016/12/16)
Compounds of formula (I) that are Fibroblast Growth Factor Inhibitors (FGFR) and are therefore useful for the treatment of diseases treatable by inhibition of FGFR are disclosed. Also disclosed are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
Selective Ligands for the Neuronal Nicotinic Receptors and Uses Thereof
-
Page/Page column 10, (2009/12/04)
The present application describes selective ligands of formula (I) for neuronal nicotinic receptors (NNRs), more specifically for the α4β2 NNR subtype, compositions thereof, and methods of using the same, wherein X, R1, X, R2, R3, L1, m, n, p, and q are defined in the specification.
Diazabicyclic central nervous system active agents
-
, (2008/06/13)
Compounds of formula I pharmaceutical compositions of these compounds, and use of said compositions to control synaptic transmission in mammals.